Table 4.
Point | AD | AMN/cAMN/cALD | p < |
---|---|---|---|
lumb-R | 3.29 ± 3.3 | 33.8 ± 42.2 | 0.05 |
leg-lat-R | 3.35 ± 3.1 | 154.0 ± 248 | 0.02 |
leg-lat-L | 4.2 ± 2.8 | 96.4 ± 187.5 | 0.01 |
leg-ant-R | 3.3 ± 3.0 | 60.3 ± 80.7 | 0.02 |
leg-ant-L | 3.6 ± 3.0 | 52.8 ± 75.1 | 0.01 |
leg-post-R | 2.9 ± 2.1 | 89.0 ± 172.3 | 0.02 |
leg-post-L | 4.3 ± 2.6 | 96.2 ± 179.6 | 0.02 |
f-ext-L | 2.3 ± 2.1 | 49.9 ± 81.9 | 0.02 |
f-int-R | 2.4 ± 2.0 | 90.3 ± 181.4 | 0.03 |
f-int-L | 2.1 ± 1.9 | 45.1 ± 81.4 | 0.01 |
Values at the 10 points where the difference between AD and AMN/cAMN/cALD male patients was significant (ANOVA, p < 0.05). Points: leg, anterior (leg-ant); lumbar (lumb); leg, lateral (leg-lat); leg, posterior (leg-post); foot, external (f-ext); foot, internal (f-int)
L left, R right